Characterizing the relationships between patient‐reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib-Reference-Cited by-同舟云学术

Characterizing the relationships between patient‐reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib

Published:2022-01-25 Issue:4 Volume:36 Page:602-609
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Winnette R.¹,Banerjee A.²,Sikirica V.³,Peeva E.⁴,Wyrwich K.¹

Affiliation:

1. Patient‐Centered Outcomes Assessment Pfizer New York NY USA

2. Early Clinical Development Pfizer Cambridge MA USA

3. Patient & Health Impact Pfizer Collegeville PA USA

4. Inflammation & Immunology Pfizer Cambridge MA USA

Funder

Pfizer

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17909

Reference15 articles.

1. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis

2. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management

3. Rethinking the classification of alopecia areata

4. Alopecia areata and health-related quality of life: a systematic review and meta-analysis

5. Psychological Impact of Alopecia Areata

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata;Expert Opinion on Drug Metabolism & Toxicology;2024-09-09

2. Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia;Australasian Journal of Dermatology;2024-05-20

3. Oral small molecule agents in management of ulcerative colitis: fact or fancy;Turkish Journal of Medical Sciences;2023-12-12

4. Alopecia areata: What's new in the diagnosis and treatment with JAK inhibitors?;The Journal of Dermatology;2023-12-12

5. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials;JEADV Clinical Practice;2023-11-07